Company profile: CTK Biotech
1.1 - Company Overview
Company description
- Provider of innovative immunodiagnostic tools and point-of-care diagnostic test kits for the IVD community worldwide, including SARS-CoV-2 rapid antigen, antibody, and real-time PCR tests; a self-administered COVID-19 home antigen test; an OnSite dengue IgG rapid test in the CDC two-step algorithm; and an HIV 1/2 antibody rapid test approved for commercialization in the EU.
Products and services
- Aridia Real-Time PCR Test: A real-time PCR assay engineered to detect SARS-CoV-2, compatible with top-scanning thermocyclers and designed to identify various SARS-CoV-2 variants
- ImmuView COVID-19 Ag Home Test: A self-administered nasal swab antigen product created for rapid SARS-CoV-2 detection, delivering results in under 15 minutes for individuals aged 14 and older
- OnSite COVID-19 Ag Rapid Test: A rapid diagnostic antigen component engineered to detect SARS-CoV-2 in nasal or nasopharyngeal specimens, producing results within 15–20 minutes.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CTK Biotech
Mega Electronics
HQ: Finland
Website
- Description: Provider of physiological monitoring technology for neurology, neurophysiology, and rehabilitation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mega Electronics company profile →
Ambu
HQ: Denmark
Website
- Description: Provider of medical devices across anaesthesia, patient monitoring & diagnostics, and emergency care. Founded in 1937, its products are relied on by millions of patients and healthcare professionals worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ambu company profile →
CTI Molecular Imaging
HQ: United States
Website
- Description: Provider of imaging solutions for the healthcare industry; CTI Molecular Imaging was acquired and now operates as Siemens Molecular Imaging, a subsidiary of Siemens Medical Solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CTI Molecular Imaging company profile →
Hemagen Diagnostics
HQ: United States
Website
- Description: Provider of product distribution via partnerships with major IVD companies where synergies exist.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemagen Diagnostics company profile →
NIMGenetics
HQ: Spain
Website
- Description: Provider of analytical diagnostic services with a Genetics unit authorized by the Consejería de Sanidad de la Comunidad de Madrid, delivered by a medically and scientifically accredited team by the Asociación Española de Genética Humana, specialized in the development and application of high genomic systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NIMGenetics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CTK Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CTK Biotech
2.2 - Growth funds investing in similar companies to CTK Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CTK Biotech
4.2 - Public trading comparable groups for CTK Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →